Business Context and Reporting Period
This Form 8-K Current Report for Aspen Aerogels, Inc. covers events occurring between May 12, 2026, and May 14, 2026. The filing details corporate governance changes, the results of the Annual Meeting of Stockholders held on May 13, 2026, and a regulatory disclosure regarding the restart of a manufacturing facility.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial data disclosed relates to executive compensation:
- Executive Compensation: Grant Thoele's annual base salary was increased to $425,000, effective April 1, 2026. His target bonus opportunity remains at 60% of his annual base salary.
Material Changes and Corporate Actions
Executive Leadership Changes
Effective May 13, 2026, Grant Thoele was designated as the Company's principal accounting officer, in addition to his existing roles as Chief Financial Officer, Treasurer, and principal financial officer. He assumed these responsibilities from Santhosh P. Daniel.
Annual Meeting Results
A quorum of 70,437,282 shares (85.04% of eligible shares) was present at the Annual Meeting. Key outcomes included:
- Director Elections: Steven R. Mitchell and Donald R. Young were elected as Class III directors.
- Auditor Ratification: KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Executive Compensation (Say-on-Pay): Stockholders approved the compensation of named executive officers on a non-binding advisory basis.
- Compensation Vote Frequency: Stockholders approved a one-year frequency for future advisory votes on executive compensation.
- Board Declassification: Stockholders approved a proposal regarding the future declassification of the Board of Directors.
Manufacturing Facility Update
On May 14, 2026, the Company issued a press release (Exhibit 99.1) announcing the initiation of a staged restart of its manufacturing facility in East Providence, Rhode Island. The Company expects to ramp up production following this restart.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the East Providence facility restart. Management expects to restore the facility to full capabilities and ramp up production, though the timeline is subject to uncertainty. The Company is leveraging external manufacturing partners to support customer demand during this period.
Risks and Contingencies: Actual results may differ materially due to the Company's ability to resume operations, manufacture the full array of products, meet customer demand, and mitigate impacts on business and financial performance. The Company is also conducting an ongoing investigation into the incident at the facility.
Investor Verification Checklist
- Verify the specific timeline and production capacity targets for the East Providence facility restart in the attached press release (Exhibit 99.1).
- Review the ongoing investigation details regarding the incident at the East Providence facility for potential operational or financial impacts.
- Confirm the implementation timeline for the Board of Directors declassification approved by stockholders.
- Monitor future filings for updates on the transition of the principal accounting officer role from Santhosh P. Daniel to Grant Thoele.